Ledger.Open graph →

SEC Form D · filed March 26, 2018

Kitov Pharma Ltd

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

TEL AVIV, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Arye Weber · Tel Aviv, L3Director Ran Tzror · Tel Aviv, L3Director Hadas Reuveni · Tel Aviv, L3Exec Gil Ben-Menachem · Tel Aviv, L3Exec · Director John Paul Waymack · Tel Aviv, L3Exec · Director Steven Steinberg · Tel Aviv, L3Director Isaac Israel · Tel Aviv, L3Exec · Director Revital Stern-Raff · Tel Aviv, L3Director Simcha Rock · Tel Aviv, L3Exec · Director Ido Agmon · Tel Aviv, L3Director Aiden S. Redmond · New York, NYExec · Director Paul Young · Exeter, NHDirector Travis York · BOSTON, MADirector Carl S. Pappo · New York, NYExec · Director Jay Bush · BOSTON, MADirector Stephen F. Waltrich · conshohocken, PAExec · Director Mark Mcgarry · BOSTON, MADirector Stavros Koutsantonis · Exeter, NHExec Kyle York · BOSTON, MAExec · Director Richard F. Lunsford · conshohocken, PADirector James S. Robertson · Houston, TXExec · Director Jeffrey Grimberg · Seattle, WADirector Steven J. Grover · Missoula, MTExec · Director Wendy W. Dicicco · Pittsburgh, PAExec · Director Quinn Rotchford · Seattle, WADirector John K. Mastrototaro · Dania Beach, FLDirector Steven K. Seger · Dania Beach, FLExec · Director Gary Pinkerton · Wall Township, NJDirector Scott Baker · Overland, KSDirector Scott Duba · Overland, KSExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗